RE:Treatment CostWay back at the time when they were testing with mice, the charging expectation was $50,000 per Canadian patient and not charging so much to be only a remedy for the richest people, assuming we kept this technology access for all Canadians regardless of whether they are rich or poor.
Dave at Bare Oaks. Canada.
Camphikefish wrote: Hi everyone, I read today that Alstiladrin treatment is expected to fall roughly between 160k and 260k per patient. 80,000 new cases per year in the US makes it a total opportunity of 1.2 billion using 160k as a multiplier. 25% of that is a realistic 300 million in sales revenue and a fair target number for 1433. Does anyone know the math from here? In orthopedics the somewhat historical buyout number has been 6 X annual sales give or take. These are US numbers alone so we could be worth 1.8 billion easily however, I realize we all believe we're worth far more. Wonder what we would be worth with worldwide numbers included? Curious again what others believe we will be bought for just for fun.